[Intravitreal angiostatic treatment of ocular vascular diseases].
Ugeskr Laeger
; 181(37)2019 Sep 09.
Article
en Da
| MEDLINE
| ID: mdl-31538583
ABSTRACT
Intraocular vascular diseases like neovascular age-related macular degeneration, diabetic macular oedema and retinal vein occlusion are associated with decline in vision if left untreated. Anti-vascular endothelia growth factor (VEGF) agents originally developed for cancer treatment were the beginning of a new treatment regime for intraocular vascular diseases. Ambiguous results exist regarding adverse effects but are considered limited. In the future, anti-VEGF agents are likely to be used for treatment of proliferative diabetic retinopathy, neovascular glaucoma and premature retinopathy.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Edema Macular
/
Inhibidores de la Angiogénesis
/
Retinopatía Diabética
Límite:
Humans
Idioma:
Da
Revista:
Ugeskr Laeger
Año:
2019
Tipo del documento:
Article